1
1
Andrew is a writer for STAT (a news site about medicine and science). Here’s what you should know about him, in plain language:
drewqjoseph.71.This is the web edition of STAT’s AAIC in 30 newsletter — a short, special “pop-up” newsletter. If you want it sent to your email inbox instead, you can sign up here.
Hello from London! Andrew, STAT’s London-based reporter, is sending the first issue of this pop-up newsletter from a big event called AAIC (a conference). He’ll be with you for the next couple of days.
A few friendly notes from Andrew:
STAT has put together a special report on dementia (a brain condition that makes memory and thinking hard), including:
They are offering a special conference discount. Here’s how to get it:
Important Point: With the currency exchange rate, $5 is less than the cost of this morning’s flat white (a foamy coffee) that Andrew bought. So it’s a bargain!
The original page includes a notice that the rest of the story is hidden behind a paywall. In simple terms:
Important: This article is exclusive to STAT+ subscribers. STAT+ is a paid club that unlocks this article — plus daily coverage and analysis of the biotech sector (medicine companies) — by subscribing. If you already have an account, you can log in. You can also view all plans. To read the rest of this story, you must subscribe to STAT+.
So the beginning is free to read, but the full article needs a paid STAT+ account.
1. What is STAT?
STAT is a news organization that writes about biopharma, science, and public health.
2. What is AAIC?
In this context, AAIC is a conference that STAT is covering with a pop-up newsletter. (It relates to brain health, given the dementia report.)
3. What is STAT+?
It’s a special paid subscription that unlocks exclusive stories like the rest of this article, plus daily biotech news.
4. How do I get the newsletter in my inbox?
Sign up using this link.
5. How can I contact Andrew privately?
Use the Signal app with handle drewqjoseph.71 or email [email protected].